Joseph E. Gilliam
PRESIDENT & COO at Glaukos; Director at Caris Life Sciences; Director at 10x Genomics. Based in Aliso Viejo, California.
- Rank
- 5713th of 14,644
- Companies held
- 3
- Largest holding
- GKOS, 96.9% of total
- Latest SEC filing
- Nov 16, 2026
What the $17.6M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Glaukos GKOS Common Stock | Directly | 71,602 | $238.10 | $17.0M | 96.9% | Form 4, Nov 16, 2026 |
| Caris Life Sciences CAI Common Stock | Directly | 29,321 | $18.54 | $544K | 3.1% | Form 4, Aug 14, 2026 |
| 10x Genomics TXG Class A Common Stock | Directly | 31 | $57.38 | $2K | 0.0% | Form 3, Oct 28, 2026 |
Share counts are the amounts Joseph E. Gilliam reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Sold | GKOS | 861 | $250.00 | $215K | View |
| Nov 12, 2026 | Sold | GKOS | 2,402 | $243.41 | $585K | View |
| Nov 12, 2026 | Sold | GKOS | 3,700 | $244.49 | $905K | View |
| Nov 12, 2026 | Sold | GKOS | 8,015 | $245.77 | $2.0M | View |
| Nov 12, 2026 | Sold | GKOS | 18,440 | $246.49 | $4.5M | View |
| Nov 12, 2026 | Sold | GKOS | 12,060 | $247.50 | $3.0M | View |
| Nov 12, 2026 | Sold | GKOS | 300 | $248.42 | $75K | View |
| Aug 11, 2026 | Sold | GKOS | 32,037 | $180.49 | $5.8M | View |
| Aug 11, 2026 | Sold | GKOS | 27,963 | $178.89 | $5.0M | View |
| May 1, 2026 | Sold | GKOS | 19,573 | $143.54 | $2.8M | View |
| Jan 22, 2026 | Sold | GKOS | 2,406 | $126.10 | $303K | View |
| Jan 22, 2026 | Sold | GKOS | 3,194 | $129.28 | $413K | View |
| Jan 22, 2026 | Sold | GKOS | 3,100 | $127.03 | $394K | View |
| Jan 22, 2026 | Sold | GKOS | 1,798 | $128.07 | $230K | View |
| Jan 21, 2026 | Sold | GKOS | 4,502 | $124.65 | $561K | View |
| Nov 18, 2025 | Sold | GKOS | 19,340 | $90.00 | $1.7M | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 5710 | Ellen R. Patterson Sr. EVP and General Counsel, Wells Fargo &. New York, NY | $17.6M |
| 5711 | Jay A. Snowden CEO and President, PENN Entertainment. Dallas, TX | $17.6M |
| 5712 | Richard Wong CFO, Fastly. San Francisco, CA | $17.6M |
| 5713 | Joseph E. Gilliam PRESIDENT & COO, Glaukos. Aliso Viejo, CA | $17.6M |
| 5714 | Que Dallara Chief Executive Officer, MiniMed Group. Northridge, CA | $17.6M |
| 5715 | Vivek Jetley President of EXL, ExlService Holdings. New York, NY | $17.6M |
| 5716 | Adam J. Greenlee President and CEO, Silgan Holdings. Norwalk, CT | $17.6M |
Other Glaukos insiders
All GKOS insiders- Thomas William Burns$369MCHAIRMAN & CEO. #577 overall
- Chris M. Calcaterra$43.2MChief Operating Officer. #2825 overall
- David F. Hoffmeister$20.9MDirector. #4088 overall
- Mark J. Foley$14.3MDirector. #6673 overall
- Aimee S. Weisner$11.8MDirector. #7321 overall
- Alex R. Thurman$10.5MSVP & CHIEF FINANCIAL OFFICER. #8501 overall
Questions
How much stock does Joseph E. Gilliam own?
Joseph E. Gilliam holds $17,593,826 in listed stock based on SEC filings and current prices, mostly Glaukos (GKOS). That ranks 5713th on the Stock Rich List.
Is this Joseph E. Gilliam's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Joseph E. Gilliam last buy or sell stock?
The most recent open-market trade on file is a sale of 861 GKOS shares on Nov 16, 2026 at $250.00.